Physiological and therapeutic effects of high frequency electrical pulses.
The results of stimulating human subjects with the LISS Cranial Stimulator (LCS) and the LISS Body Stimulator (LBS) include an increase or decrease in the activities of certain neurotransmitters and neurohormones and the reduction of associated pain, insomnia, depression, and spasticity. The effects were documented in human subjects with measurements of the serum concentration of the various agents and assessments of the symptoms being performed before and after stimulation. The stimulators had a carrier frequency of 15,000 hz, which utilizes the bulk capacitance of the body, and a 15 hz modulating bioactive frequency. The second modulating frequency presently used, 500 hz, reduces the energy input to the patient by half. Significant increases in levels of CSF serotonin and beta endorphin were recorded post stimulation. There were also elevations in the levels of plasma serotonin, beta endorphin, GABA and DHEA together with diminished levels of cortisol and tryptophan. Concomitant with these changes were significant improvements in the symptoms of pain, insomnia, spasticity, depression, and headache.
Liss
S
S
MEDI Consultants, Inc., Paterson, New Jersey 07504, USA.
Liss
B
B
D000328:Adult; D000368:Aged; D001921:Brain / Q000502:physiology*; D001923:Brain Chemistry / Q000502:physiology; D002940:Circadian Rhythm; D004558:Electric Stimulation / Q000295:instrumentation; D004599:Electric Stimulation Therapy; D005260:Female; D006728:Hormones / Q000134:cerebrospinal fluid; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000628:therapy; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000134:cerebrospinal fluid; D059408:Pain Management; D004561:Transcutaneous Electric Nerve Stimulation
D006728:Hormones; D018377:Neurotransmitter Agents